MD Anderson Cancer Center Leukemia Department — Houston, Texas

MD Anderson Cancer Center Leukemia Department is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center Leukemia Department has participated in 1 clinical trials.

Therapeutic areas: Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center Leukemia Department?

MD Anderson Cancer Center Leukemia Department has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center Leukemia Department conducted?

MD Anderson Cancer Center Leukemia Department has 1 clinical trials on record. Their work covers Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis.

Is MD Anderson Cancer Center Leukemia Department accredited by Crixeo Health?

MD Anderson Cancer Center Leukemia Department has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center Leukemia Department?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.